UBS AM’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,273,894
| Closed | -$13M | – | 2667 |
|
|
2023
Q2 | $13M | Hold |
2,273,894
| – | – | 0.01% | 875 |
|
|
2023
Q1 | $13M | Sell |
2,273,894
-62,050
| -3% | -$354K | 0.01% | 875 |
|
|
2022
Q4 | $14.1M | Sell |
2,335,944
-66,651
| -3% | -$403K | 0.01% | 834 |
|
|
2022
Q3 | $15.9M | Sell |
2,402,595
-17,932
| -0.7% | -$119K | 0.01% | 825 |
|
|
2022
Q2 | $12.6M | Sell |
2,420,527
-1,800
| -0.1% | -$9.4K | 0.01% | 876 |
|
|
2022
Q1 | $16.7M | Buy |
2,422,327
+908,641
| +60% | +$6.27M | 0.01% | 892 |
|
|
2021
Q4 | $18.8M | Buy |
1,513,686
+30,367
| +2% | +$378K | 0.01% | 912 |
|
|
2021
Q3 | $46.4M | Buy |
1,483,319
+195,584
| +15% | +$6.11M | 0.02% | 640 |
|
|
2021
Q2 | $36.9M | Buy |
1,287,735
+644,756
| +100% | +$18.5M | 0.02% | 709 |
|
|
2021
Q1 | $27.9M | Buy |
642,979
+126,950
| +25% | +$5.5M | 0.01% | 783 |
|
|
2020
Q4 | $36.9M | Sell |
516,029
-210,434
| -29% | -$15.1M | 0.02% | 687 |
|
|
2020
Q3 | $21.9M | Buy |
+726,463
| New | +$21.9M | 0.01% | 740 |
|